1. Home
  2. U vs GKOS Comparison

U vs GKOS Comparison

Compare U & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Unity Software Inc.

U

Unity Software Inc.

HOLD

Current Price

$29.59

Market Cap

8.0B

Sector

Technology

ML Signal

HOLD

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$147.89

Market Cap

8.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
U
GKOS
Founded
2004
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.0B
8.7B
IPO Year
2020
2015

Fundamental Metrics

Financial Performance
Metric
U
GKOS
Price
$29.59
$147.89
Analyst Decision
Buy
Strong Buy
Analyst Count
21
12
Target Price
$36.61
$126.92
AVG Volume (30 Days)
7.2M
878.3K
Earning Date
05-07-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
42.86
N/A
EPS
N/A
N/A
Revenue
$1,849,648,000.00
$507,442,000.00
Revenue This Year
$15.81
$23.32
Revenue Next Year
$12.93
$27.43
P/E Ratio
N/A
N/A
Revenue Growth
2.01
32.33
52 Week Low
$16.78
$73.16
52 Week High
$52.15
$148.62

Technical Indicators

Market Signals
Indicator
U
GKOS
Relative Strength Index (RSI) 57.64 66.35
Support Level $24.82 $96.44
Resistance Level $29.96 N/A
Average True Range (ATR) 1.43 5.50
MACD 0.18 1.62
Stochastic Oscillator 70.83 90.25

Price Performance

Historical Comparison
U
GKOS

About U Unity Software Inc.

Unity Software Inc provides a software platform for creating and operating interactive, real-time 3D content. The platform can be used to create, run, and monetize interactive, real-time 2D and 3D content for mobile phones, tablets, PCs, consoles, and augmented and virtual reality devices. The business is spread across the United States, Greater China, EMEA, APAC, and other Americas, and key revenue is derived from the EMEA region. Its products are used in the gaming industry, retail, automotive, architecture, engineering, and construction.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: